Profound Medical Corp.
Profound Medical Corp. (PROF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
prof · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$12.00
Consensus
$12.00
+82.6% upside
Low
$12.00
Median: $12 · Last Close: $6.57
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $6.41 | ↓ 2.37% |
1-day model range: $6.38–$6.45. Peak: $6.45 (-2.37%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -38.7% |
| 2028 | $3 | -50.6% |
| 2029 | $3 | -55.4% |
| 2030 | $3 | -57.6% |
| 2031 | — | -58.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PROF · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-01-07 | Lake Street | Maintains | Buy→Buy |
| 2025-04-23 | Lake Street | Maintains | Buy→Buy |
| 2024-07-16 | Stifel | Upgrade ↑ | Hold→Buy |
| 2024-03-11 | Alliance Global Partners | Maintains | Buy→Buy |
| 2024-03-08 | Stifel | Maintains | Hold→Hold |
| 2024-01-04 | Alliance Global Partners | Maintains | Buy→Buy |
| 2023-08-04 | Raymond James | Downgrade ↓ | Strong Buy→Outperform |
| 2023-05-11 | Alliance Global Partners | Maintains | Buy→Buy |
| 2023-05-11 | TD Cowen | Maintains | Outperform→Outperform |
| 2023-03-21 | Jefferies | Downgrade ↓ | Buy→Equal Weight |
Wall Street analysts have recently issued updated ratings on Profound Medical Corp. (PROF) stock. Of the recent 13 rating actions, 2 were upgrades and 3 were downgrades. 7 analysts currently cover PROF.
Analyst Recommendation Trends
PROF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$26M
↓ 65.7% YoY
Revenue Next Year
$44M
↑ 69.3% YoY
EPS This Year
$-0.84
EPS Next Year
$-0.75
↓ 10.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast PROF EPS of $-0.84 for the current fiscal year, based on estimates from 4 analysts. The PROF revenue forecast is $26M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PROF stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PROF price target is $12.00 (+82.6% upside), with an analyst consensus of Buy.
The PROF short-term stock prediction for tomorrow is $6.41 (-2.37%). The PROF stock price prediction for 2027 estimates an average of $4. The PROF stock prediction for 2030 projects a range of $3–$3.
Profound Medical Corp. trades on NASDAQ under the ticker PROF. The PROF stock outlook for 2027 is broadly positive, supported by a Buy consensus among 86% of covering analysts.
Frequently asked questions
PROF forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month PROF price target is $12.00, with a high forecast of $12.00 and a low of $12.00. The median price target is shown in the chart above when available. This implies +82.6% potential upside from the current price of $6.57.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.